is semaglutide patented Novo Nordisk Settles Ozempic Patent Case Patent expires next year: Novo

Last but not least, given the recency of these prescribing trends, no long-term data on the next-generation effects of these medications is available, leading to several uncertainties about the possibility and implications of long-term use

The trial data doesnt capture much of this

Following the lead of its chief competitor, the states second-largest health insurer is significantly scaling back its coverage of costly GLP-1 drugs when used for weight loss beginning next year

Frontiers In Endocrinology

[1] [2] The medication works by binding to GLP-1 receptors in pancreatic beta cells, enhancing glucose-dependent insulin secretion, suppressing glucagon release, and slowing gastric emptying